医学
宫颈癌
入射(几何)
流行病学
人口学
癌症
民族
人口
监测、流行病学和最终结果
死亡率
妇科
老年学
癌症登记处
环境卫生
内科学
物理
光学
社会学
人类学
作者
Meg Watson,Mona Saraiya,Vicki B. Benard,Steven S. Coughlin,Lisa Flowers,Vilma Cokkinides,Molly Schwenn,Youjie Huang,Anna R. Giuliano
出处
期刊:Cancer
[Wiley]
日期:2008-11-03
卷期号:113 (S10): 2855-2864
被引量:232
摘要
Recent interest in human papillomavirus (HPV)-associated cancers and the availability of several years of data covering 83% of the US population prompted this descriptive assessment of cervical cancer incidence and mortality in the US during the years 1998 through 2003. This article provides a baseline for monitoring the impact of the HPV vaccine on the burden of cervical cancer over time.Data from 2 federal cancer surveillance programs, the Centers for Disease Control and Prevention (CDC)'s National Program of Cancer Registries and the National Cancer Institiute's Surveillance, Epidemiology, and End Results Program, were used to examine cervical cancer incidence by race, Hispanic ethnicity, histology, stage, and US census region. Data from the CDC's National Center for Health Statistics were used to examine cervical cancer mortality by race, Hispanic ethnicity, and US census region.The incidence rate of invasive cervical cancer was 8.9 per 100,000 women during 1998 through 2003. Greater than 70% of all cervical carcinomas were squamous cell type, and nearly 20% were adenocarcinomas. Cervical carcinoma incidence rates were increased for black women compared with white women and for Hispanic women compared with non-Hispanic women. Hispanic women had increased rates of adenocarcinomas compared with non-Hispanic women. The South had increased incidence and mortality rates compared with the Northeast.Disparities by race/ethnicity and region persist in the burden of cervical cancer in the US. Comprehensive screening and vaccination programs, as well as improved surveillance, will be essential if this burden is to be reduced in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI